iShares U.S. Healthcare ETF News - August 28, 2026

🟢 Health ETF (IYH) is trading 5.9% up in pre-market after FDA approval for Mounjaro’s cardiovascular-risk reduction

IYH is trading at $76.90 (+5.88%) in pre-market after Eli Lilly received FDA approval for Mounjaro to reduce cardiovascular-event risk. - The approval...

Revolution Medicines wins FDA approval, doubling survival in pancreatic cancer patients

The U.S. Food and Drug Administration granted expedited approval to Revolution Medicines' new drug, daraxonrasib (brand name: Rasonque). This first-of-its-kind...